Clinical Trial Update: A Study to Explore Association Patterns Between Digital Outcome Assessments From the Konectom™ Platform and Magnetic Resonance Imaging (MRI) Measures of Brain Tissue Damage

View source ↗

Summary

Biogen-sponsored study completed to explore how digital outcome assessments from the Konectom platform relate to MRI measures of brain tissue damage in multiple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: Biogen | Conditions: Multiple Sclerosis (MS) | Status: COMPLETED